Concepedia

Author

Sarah Kammerer

Brandenburg University of Technology Cottbus-SenftenbergORCID

Also Known As

S Kammerer, S. Kammerer, S. Kämmerer, Sarah Kammerer

40

Publications

803

Citations

17

H-Index

38

Concepts

All Affiliations

Brandenburg University of Technology Cottbus-SenftenbergFraunhofer Institute for Cell Therapy and ImmunologyMedical University of GrazCharles UniversityUniversity of Hradec Králové
SK

About

Sarah Kammerer is an author at Brandenburg University of Technology Cottbus-Senftenberg specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

124

2

Biochemistry

2

2

34

3

Cell Biology

2

2

41

4

Health Sciences

1

1

39

5

Gastroenterology

1

1

39

Sarah Kammerer

×

20

Publications

609

Citations

15

H-Index

YearCitations

Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line

Chouyang Li, Simin Rezania, Sarah Kammerer,

Scientific Reports

2015

164

ATP-based cell viability assay is superior to trypan blue exclusion and XTT assay in measuring cytotoxicity of anticancer drugs Taxol and Imatinib, and proteasome inhibitor MG-132 on human hepatoma cell line HepG2

Elisabeth Nowak, Sarah Kammerer, Jan‐Heiner Küpper

Clinical Hemorheology and Microcirculation

2018

48

Human hepatocyte systems for in vitro toxicology analysis

Sarah Kammerer, Jan‐Heiner Küpper

Journal of Cellular Biotechnology

2018

47

Abdominal and pelvic CT: is positive enteric contrast still necessary? Results of a retrospective observational study

Sarah Kammerer, Anna Janina Höink, Hauke Heinzow,

European Radiology

2014

39

Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR

Sue Ellen Verbrugge, Marjon Al, Yehuda G. Assaraf,

Oncotarget

2015

30

Brivanib Exhibits Potential for Pharmacokinetic Drug–Drug Interactions and the Modulation of Multidrug Resistance through the Inhibition of Human ABCG2 Drug Efflux Transporter and CYP450 Biotransformation Enzymes

Jakub Hofman, Aleš Šorf, Dimitrios Vagiannis,

Molecular Pharmaceutics

2019

28

Synthesis of cyclophosphamide metabolites by a peroxygenase from Marasmius rotula for toxicological studies on human cancer cells

Susanne Steinbrecht, Jan Kiebist, Rosalie König,

AMB Express

2020

28

Metabolic activity testing can underestimate acute drug cytotoxicity as revealed by HepG2 cell clones overexpressing cytochrome P450 2C19 and 3A4

Susanne Steinbrecht, Rosalie König, Kai‐Uwe Schmidtke,

Toxicology

2018

24

Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme

Dimitrios Vagiannis, Eva Novotná, Adam Skarka,

Cancers

2020

23

Impact of resection on overall survival of recurrent Glioblastoma in elderly patients

Jasmin Hager, Eva Herrmann, Sarah Kammerer,

Clinical Neurology and Neurosurgery

2018

22

Page 1